Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Gérald Raverot"'
Autor:
Julien Forestier, Philip Robinson, Catherine Lombard-Bohas, Gérald Raverot, Laurent Milot, Annie Lemelin, Françoise Borson-Chazot, Lucia Hue-Fontaine, Thomas Walter
Publikováno v:
Clinics and Research in Hepatology and Gastroenterology
Clinics and Research in Hepatology and Gastroenterology, Elsevier, 2020, 44, pp.954-960. ⟨10.1016/j.clinre.2020.02.011⟩
Clinics and Research in Hepatology and Gastroenterology, Elsevier, 2020, 44, pp.954-960. ⟨10.1016/j.clinre.2020.02.011⟩
To explore potential synergy in effectiveness between metformin and everolimus, 2 inhibitors of the mTOR pathway, for neuroendocrine tumours (NET).A cohort of patients with advanced gastroenteropancreatic or lung NETs treated by everolimus were strat
Autor:
Domenico Solari, Emmanuel Jouanneau, Luigi Maria Cavallo, Federico Frio, Paolo Cappabianca, Gérald Raverot
Publikováno v:
World Neurosurgery. 132:e869-e877
Objective Treatment of cystic craniopharyngiomas can be challenging and recurrences are frequent, even after total resection. In selected cases, less-aggressive surgery with the sole drainage of the cyst reliefs symptoms caused by mass effect and rep
Autor:
Mirela Diana Ilie, Alexandre Vasiljevic, Marie Chanal, Nicolas Gadot, Laura Chinezu, Emmanuel Jouanneau, Ana Hennino, Gérald Raverot, Philippe Bertolino
Publikováno v:
Acta Neuropathologica Communications, Vol 10, Iss 1, Pp 1-15 (2022)
Folliculostellate cells are S100B-expressing cells with numerous functions in the normal anterior pituitary. These cells have also been identified in pituitary neuroendocrine tumours (PitNETs), where their precise role remains elusive. Here, we aimed
Autor:
Thierry Brue, Philippe Chanson, Patrice Rodien, Brigitte Delemer, Delphine Drui, Lucile Marié, Laurène Juban, Lara Salvi, Robin Henocque, Gérald Raverot
Publikováno v:
Frontiers in Endocrinology
Frontiers in Endocrinology, Frontiers, 2021, 12, ⟨10.3389/fendo.2021.745843⟩
Frontiers in Endocrinology, 2021, 12, ⟨10.3389/fendo.2021.745843⟩
Frontiers in Endocrinology, Vol 12 (2021)
Frontiers in Endocrinology, Frontiers, 2021, 12, ⟨10.3389/fendo.2021.745843⟩
Frontiers in Endocrinology, 2021, 12, ⟨10.3389/fendo.2021.745843⟩
Frontiers in Endocrinology, Vol 12 (2021)
ObjectiveEfficacy of pharmacological treatments for acromegaly has been assessed in many clinical or real-world studies but no study was interested in economics evaluation of these treatments in France. Therefore, the objective of this study was to e
Autor:
Hélène Lasolle, Marie Teulade, Véronique Lapras, Alexandre Vasiljevic, Françoise Borson-Chazot, Emmanuel Jouanneau, Gérald Raverot
Publikováno v:
Annales d'endocrinologie. 83(1)
Dopaminergic agonists (DA) are the first-line treatment in lactotroph pituitary tumor but treatment usually needs to be life-long. After surgical transsphenoid resection, remission rates range from 60 to 90%, with low morbidity.The objective was to e
Autor:
Pauline Sarkis, Muriel Rabilloud, Jean-Christophe Lifante, Anna Siamand, Emmanuel Jouanneau, Emmanuel Gay, Philippe Chaffanjon, Olivier Chabre, Gérald Raverot
Publikováno v:
Annales d'Endocrinologie
Annales d'Endocrinologie, 2019, 80, pp.32-37. ⟨10.1016/j.ando.2018.01.002⟩
Annales d'Endocrinologie, Elsevier Masson, 2019, 80, pp.32-37. ⟨10.1016/j.ando.2018.01.002⟩
Annales d'Endocrinologie, 2019, 80, pp.32-37. ⟨10.1016/j.ando.2018.01.002⟩
Annales d'Endocrinologie, Elsevier Masson, 2019, 80, pp.32-37. ⟨10.1016/j.ando.2018.01.002⟩
Bilateral adrenalectomy (BADX) has become an important treatment of Cushing's disease (CD), especially when other treatment options have failed. The aim of this study was to evaluate the long-term quality of life (QoL) of patients having undergone BA
Autor:
Robin Henocque, Thierry Brue, Brigitte Delemer, Yves Brault, Christine Cortet-Rudelli, Gérald Raverot, Hervé Lefebvre, Rachel Desailloud, Isabelle Raingeard, Philippe Caron, Sara Barraud, Philippe Chanson
Publikováno v:
Annales d'Endocrinologie
Annales d'Endocrinologie, Elsevier Masson, 2021, 82 (6), pp.582-589. ⟨10.1016/j.ando.2021.05.004⟩
Annales d'Endocrinologie, Elsevier Masson, 2021, 82 (6), pp.582-589. ⟨10.1016/j.ando.2021.05.004⟩
Objective We report the final analysis of the French ACROSTUDY, using data revised and enriched since the 2013 interim analysis. Our objective was to validate the use of pegvisomant (PEGV) in the treatment of acromegaly and to determine efficacy and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::256050e0d0ba76fe220f37799c66c569
https://hal.archives-ouvertes.fr/hal-03366670
https://hal.archives-ouvertes.fr/hal-03366670
Autor:
Catherine Cardot-Bauters, Francoise Archambeaud-Mouveroux, Muriel Houang, M.O. North, Gérald Raverot, Stéphanie Espiard, Anne Lienhardt, Hervé Lefebvre, Muriel Bottineau, Fidéline Bonnet, Denis Duboc, Olivier Chabre, Marie-Laure Nunes, Jérôme Bertherat, Antoine Feydy, Nicolas Dupin, Marie-Christine Vantyghem, Guillaume Assié, Sebastian Stroër, Françoise Brucker-Davis, L. Cabanes, Sophie Grabar, Antoine Tabarin, Lionel Groussin, Laurence Guignat
Publikováno v:
Yearbook of Paediatric Endocrinology.
Introduction Carney Complex (CNC) is a rare multiple endocrine and nonendocrine neoplasia syndrome. Manifestations and genotype-phenotype correlations have been described by retrospective studies, but no prospective study evaluating the occurrence of
Autor:
Carine Courtillot, Marie Laure Nunes, Jérôme Bertherat, Philippe Caron, Lucie Allard, Walid Choucha, Christel Jublanc, C. Cortet, Frédérique Albarel, Philippe Chanson, Dominique Maiter, Brigitte Delemer, Emmanuelle Corruble, Sylvie Salenave, Julie Sarfati, Gérald Raverot
Publikováno v:
European journal of endocrinology. 183(2)
Context In patients treated with antipsychotics, the rare occurrence of a macroprolactinoma represents a therapeutic challenge. Objective Our aim was to evaluate the efficacy and psychiatric safety of dopamine agonists (DAs) prescribed for large macr
Autor:
Ilan Shimon, Thierry Brue, Gérald Raverot, Laura De Marinis, Maria Fleseriu, Mônica R. Gadelha, Pritam Gupta, Annamaria Colao, Jürgen Fleck, Marcello D. Bronstein, Alberto M Pedroncelli, Mirtha Guitelman
Publikováno v:
European Journal of Endocrinology
European Journal of Endocrinology, BioScientifica, 2020, 182 (6), pp.583. ⟨10.1530/EJE-19-0762⟩
European Journal of Endocrinology, 2020, 182 (6), pp.583. ⟨10.1530/EJE-19-0762⟩
European Journal of Endocrinology, BioScientifica, 2020, 182 (6), pp.583. ⟨10.1530/EJE-19-0762⟩
European Journal of Endocrinology, 2020, 182 (6), pp.583. ⟨10.1530/EJE-19-0762⟩
Objective In the Phase III PAOLA study (clinicaltrials.gov: NCT01137682), enrolled patients had uncontrolled acromegaly despite ≥6 months of octreotide/lanreotide treatment before study start. More patients achieved biochemical control with long-ac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::199e0366d51d319ae0248fa06ddbaa60
https://hal-amu.archives-ouvertes.fr/hal-03222577
https://hal-amu.archives-ouvertes.fr/hal-03222577